5 years ago

Manus Neurodynamica Secures £1.2M to Launch Digital Pen for Parkinson's Detection

  • Edinburgh-based medtech company Manus Neurodynamica has raised £1.2 million in funding to launch its digital pen for early detection of Parkinson's disease

  • The NeuroMotor Pen analyzes hand movements to detect early signs of neurological conditions

  • The funding round was led by the North East Innovation Fund, with participation from Northstar Ventures, SIS Ventures, and Old College Capital

  • This brings the total investment in Manus to £5 million

  • The company plans to launch the pen in the UK and Benelux markets later this year and is in talks with NHS to supply the pens.

      • ProblemHealthcare

      "Early diagnosis of Parkinson's disease is crucial for effective treatment and management, but current methods can be expensive, invasive, and time-consuming. Many people with Parkinson's are diagnosed late, when symptoms are more severe and treatment options are limited."

      Solution

      "Manus has developed a digital pen that uses sensors to analyze hand movements and detect early signs of Parkinson's disease. This pen is a quick, inexpensive, and non-invasive alternative to traditional diagnostic methods, making it easier and more accessible for people to get diagnosed early."

      Covered on